Search
for
Sort by
Research 301–330 of 1000+
- Efficacy and Tolerability of Brevilin-A, a Natural JAK Inhibitor, in Pediatric Alopecia Areata: A Case Series
- Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata
- Alopecia Universalis Treated With Tofacitinib: The Role of JAK/STAT Inhibitors in Hair Regrowth
- 84 Partial restoration of scalp microbiota in alopecia areata with JAK inhibitors
- Screening for latent infectious disease in patients with alopecia areata before initiating JAK inhibitors therapy: a single-center real-world retrospective study
- Case report: Dupilumab therapy for alopecia areata in a 4-year-old patient resistant to baricitinib
- Tofacitinib: A Promising Treatment for Adolescent Alopecia Areata
- Baricitinib for alopecia areata
- SnapshotDx Quiz: September 2018
- Real‐World Outcomes and Safety of JAK Inhibitors in Paediatric Alopecia Areata: A Retrospective Multicentre Study
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Comparative Efficacy of JAK Inhibitors in Acute vs Nonacute Alopecia Areata: A Retrospective Cohort Study
- Björnstad Syndrome With Late‐Onset Alopecia Mimicking Androgenetic Alopecia: Histopathological and Genetic Findings
- 0433 JAK inhibitor halts the progression of acute exacerbation of alopecia areata
- Hair loss disorders (alopecias)
- Experience in treating multifocal alopecia areata in a child with Jak kinase inhibitors
- A Bibliometric Analysis of Alopecia Areata Literature over the Past 50 Years.
- Successful Treatment of Severe Alopecia Areata With Oral or Topical Tofacitinib.
- IN-SILICO STUDY OF BIOACTIVE COMPOUNDS OF NATURAL MATERIALS AS A JAK- SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION INHIBITOR FOR ANTI-ALOPECIA
- TĘTNIAK AORTY NA OSI CZASU – CZY, KIEDY I JAK LECZYĆ
- Epigallocatechin-3 Gallate Inhibits STAT-1/JAK2/IRF-1/HLA-DR/HLA-B and Reduces CD8 MKG2D Lymphocytes of Alopecia Areata Patients
- Predominant expression of interleukin (IL)‐17 in chronic alopecia areata compared to IFN‐γ in pathogenic Th17 cells, tissue‐resident memory T cells and natural killer cells
- Detection of Serum Levels of Interleukins-17, 21, 6 and Tumor Necrosis Factor-α in Patients with Patchy Alopecia Areata and Their Association with Disease Severity
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Recalcitrant alopecia areata responsive to leflunomide and anthralin—Potentially undiscovered JAK/STAT inhibitors?
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- JAK Inhibitor Therapy in Alopecia Areata with Latent Hepatitis B Virus or Tuberculosis Infection: A Safety Assessment
- New Treatment Strategies in Management of Alopecia Areata: Review Article
- Tofacitinib therapy for children with severe alopecia areata